18F-DOPA PET/CT and neuroendocrine tumours.
Nanni
Cristina
C
Rubello
Domenico
D
Fanti
Stefano
S
D004295:Dihydroxyphenylalanine / Q000031:analogs & derivatives*; D019788:Fluorodeoxyglucose F18; D006801:Humans; D018358:Neuroendocrine Tumors / Q000000981:diagnostic imaging*; D049268:Positron-Emission Tomography / Q000379:methods*; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians' / Q000639:trends; D019275:Radiopharmaceuticals; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D013382:Subtraction Technique; D014057:Tomography, X-Ray Computed / Q000379:methods*
D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18; C043437:fluorodopa F 18; D004295:Dihydroxyphenylalanine